CINCINNATI , Nov. 6, 2024 /PRNewswire/ -- Meridian Bioscience, Inc., a leader in global diagnostics and life science materials and creator of the LeadCare ® II Blood Lead Testing System, is pleased to announce its victory in the Centers for Disease Control and Prevention's (CDC) Lead Detect Prize.
This prestigious competition fostered the development of innovative, rapid lead detection technologies at the point of care, significantly enhancing public health efforts to prevent lead exposure and increase the accessibility of blood lead testing. The Lead Detect Prize was established to accelerate the development of innovative point-of-care blood lead testing technologies. The challenge aimed to enhance testing solutions by providing funding and expertise and promoting partnerships.
Five winners shared a $150,000 prize in the first phase and received exclusive access to a second phase that included a virtual accelerator. The second phase concluded with three winners dividing an $850,000 prize pool, with Meridian Bioscience taking home the first prize of $500,000 . Meridian's winning submission, detailing its vision for a next-generation blood lead testing system at the point of care, met or exceeded 100% of the challenge criteria.
Meridian's entry capitalized on the company's extensive experience and leadership in point-of-care lead testing, as demonstrated by the widespread use of the LeadCare II analyzer. This easy-to-use device has been crucial in enabling accessible and imme.
